Related references
Note: Only part of the references are listed.Cooperativity in Virus Neutralization by Human Monoclonal Antibodies to Two Adjacent Regions Located at the Amino Terminus of Hepatitis C Virus E2 Glycoprotein
Zhenyong Keck et al.
JOURNAL OF VIROLOGY (2013)
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
John Lok Man Law et al.
PLOS ONE (2013)
Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape
Thomas Krey et al.
PLOS PATHOGENS (2013)
Future perspectives: towards interferon-free regimens for HCV
Ed Gane
ANTIVIRAL THERAPY (2012)
Naturally Occurring Antibodies That Recognize Linear Epitopes in the Amino Terminus of the Hepatitis C Virus E2 Protein Confer Noninterfering, Additive Neutralization
Alexander W. Tarr et al.
JOURNAL OF VIROLOGY (2012)
Toward a Hepatitis C Virus Vaccine: the Structural Basis of Hepatitis C Virus Neutralization by AP33, a Broadly Neutralizing Antibody
Jane A. Potter et al.
JOURNAL OF VIROLOGY (2012)
Structure of Hepatitis C Virus Envelope Glycoprotein E2 Antigenic Site 412 to 423 in Complex with Antibody AP33
Leopold Kong et al.
JOURNAL OF VIROLOGY (2012)
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
Jorge Reyes-del Valle et al.
JOURNAL OF VIROLOGY (2012)
Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1
Leopold Kong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
Erick Giang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a Isolate
Zhen-yong Keck et al.
PLOS PATHOGENS (2012)
Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees
Trevor J. Morin et al.
PLOS PATHOGENS (2012)
Boceprevir: a novel nonstructural 3 (NS3) protease inhibitor for the treatment of chronic hepatitis C infection
Paul Y. Kwo
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2012)
Evolving epidemiology of hepatitis C virus
D. Lavanchy
CLINICAL MICROBIOLOGY AND INFECTION (2011)
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
Michael L. Washburn et al.
GASTROENTEROLOGY (2011)
Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants
Whitney E. Purtha et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Vaccine-Induced Cross-Genotype Reactive Neutralizing Antibodies Against Hepatitis C Virus
Jean-Christophe Meunier et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Hypervariable Region 1 Differentially Impacts Viability of Hepatitis C Virus Strains of Genotypes 1 to 6 and Impairs Virus Neutralization
Jannick Prentoe et al.
JOURNAL OF VIROLOGY (2011)
Neutralizing Monoclonal Antibodies against Hepatitis C Virus E2 Protein Bind Discontinuous Epitopes and Inhibit Infection at a Postattachment Step
Michelle C. Sabo et al.
JOURNAL OF VIROLOGY (2011)
A genetically humanized mouse model for hepatitis C virus infection
Marcus Dorner et al.
NATURE (2011)
A Weak Neutralizing Antibody Response to Hepatitis C Virus Envelope Glycoprotein Enhances Virus Infection
Keith Meyer et al.
PLOS ONE (2011)
A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques
Pierre Garrone et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope Glycoproteins
Ranjit Ray et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes
Dorothea Bankwitz et al.
JOURNAL OF VIROLOGY (2010)
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Paul Y. Kwo et al.
LANCET (2010)
Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography
James E. Voss et al.
NATURE (2010)
Structural changes of envelope proteins during alphavirus fusion
Long Li et al.
NATURE (2010)
Telaprevir for Previously Treated Chronic HCV Infection.
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
Sharon E. Frey et al.
VACCINE (2010)
Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus
Teresa J. Broering et al.
JOURNAL OF VIROLOGY (2009)
HCV selection and HVR1 evolution in a chimpanzee chronically infected with HCV-1 over 12 years
Ling Lu et al.
HEPATOLOGY RESEARCH (2008)
Use of Enhanced Surveillance for Hepatitis C Virus Infection to Detect a Cluster Among Young Injection-Drug Users—New York, November 2004–April 2007
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Definition of a conserved immunodominant domain on hepatitis C virus E2 glycoprotein by neutralizing human monoclonal antibodies
Zhen-Yong Keck et al.
JOURNAL OF VIROLOGY (2008)
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
Mansun Law et al.
NATURE MEDICINE (2008)
Isolation and characterization of broadly neutralizing human monoclonal antibodies to the E1 glycoprotein of hepatitis C virus
Jean-Christophe Meunier et al.
JOURNAL OF VIROLOGY (2008)
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
Zania Stamataki et al.
VACCINE (2007)
Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus
Daniel X. Johansson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice
Hisaya Azuma et al.
NATURE BIOTECHNOLOGY (2007)
Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma
Pei Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees
Gamal A. Elmowalid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy
Mansun Law et al.
JOURNAL OF VIROLOGY (2007)
Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding
Ania M. Owsianka et al.
JOURNAL OF VIROLOGY (2006)
A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry
Heidi E. Drummer et al.
JOURNAL OF VIROLOGY (2006)
Enhancement of immune responses to an HBV DNA vaccine by electroporation
A Luxembourg et al.
VACCINE (2006)
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33
AW Tarr et al.
HEPATOLOGY (2006)
Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity
DJ Schofield et al.
HEPATOLOGY (2005)
Robust hepatitis C virus infection in vitro
J Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera
P Meuleman et al.
HEPATOLOGY (2005)
Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells
M Brazzoli et al.
VIROLOGY (2005)
Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus
D Lavillette et al.
HEPATOLOGY (2005)
Global epidemiology of hepatitis C virus infection
CW Shepard et al.
LANCET INFECTIOUS DISEASES (2005)
Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein
Y Modis et al.
JOURNAL OF VIROLOGY (2005)
Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein
A Owsianka et al.
JOURNAL OF VIROLOGY (2005)
Human monoclonal antibody to hepatitis C virus El glycoprotein that blocks virus attachment and viral infectivity
ZY Keck et al.
JOURNAL OF VIROLOGY (2004)
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
M Hsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes
B Bartosch et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites
A Fournillier et al.
JOURNAL OF VIROLOGY (2001)
Hepatitis C virus replication in mice with chimeric human livers
DF Mercer et al.
NATURE MEDICINE (2001)
Coexpression of hepatitis C virus envelope proteins E1 and E2 in cis improves the stability of membrane insertion of E2
L Cocquerel et al.
JOURNAL OF GENERAL VIROLOGY (2001)
The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization
AO De Beeck et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies
P Farci et al.
SCIENCE (2000)
Share Paper
